
|Videos|October 6, 2017
What Were the Top-line Data Results from the LEAP-1 Study?
Author(s)Contagion® Editorial Staff
Steven Gelone, PharmD, shares the topline data yielded from the LEAP-1 study.
Advertisement
Steven Gelone, PharmD, chief scientific officer at Nabriva Therapeutics, shares the topline data yielded from the LEAP-1 study.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
Measles Update: January 30, 2026
2
Vaccines and Febrile Seizures: What Everyone Should Know
3
FDA Clears MicuRx’s IND for MRX-5, Paving the Way for Phase 2a Trial in Hard-to-Treat NTM Lung Disease
4
HIV Spending for Fiscal Year 2026: The Latest Update
5

































































































































